Gil Kliman

Venus: A Global Leader In The Medical Aesthetics Industry We use cutting-edge technology to develop safe, non-invasive devices that address todays most in-demand aesthetic needs. As a leading medical aesthetic device company, we are currently present in over 60 countries and 29 direct markets with more than 10 million Venus treatments performed worldwide annually. Staying connected to our customers enables us to be focused on their needs and expectations and always provide them with the highest level of care – this is the essence of Aesthetic intelligence. Our latest innovations like Venus Bliss MAX™ the 3-in1-body shaping solution, ARTAS iXi® the A.I. hair restoration robot, NeoGraft®, Venus Legacy,™ Venus Velocity,™ Venus Viva™ MD—are setting higher industry standards and improving the quality of life for hundreds of thousands of patients worldwide. Looking to try a treatment? Find a certified provider near you: ‪http://www.venustreatments.com Are you a physician? Find out more: www.venus.ai

Avedro is a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic disorders and improving vision to reduce dependency on eyeglasses or contact lenses. Avedro’s proprietary Avedro Corneal Remodeling Platform strengthens, stabilizes and reshapes the cornea utilizing corneal cross-linking in minimally invasive and non-invasive outpatient procedures to treat corneal ectatic disorders and correct refractive conditions. The Avedro Corneal Remodeling Platform is comprised of Avedro’s KXL and Mosaic systems, each of which delivers ultraviolet A light, and a suite of proprietary single-use riboflavin drug formulations, which, when applied together to the cornea, induce a biochemical reaction called corneal collagen cross-linking.

GoCheck’s apps detect common vision disorders early, while they can still be treated. Our first product, GoCheck Kids, serves over 6,000 pediatric teams in the U.S. and Europe in their quest to prevent vision impairment, the most prevalent disabling condition among children in the U.S. and many countries. Vision diseases usually lead to compromised learning, blindness, and even death. GoCheck Kids made early screening affordable, reducing the cost by over 60% by leveraging the iPhone’s manufacturing scale. It’s also FDA-registered and CE certified. Eight of the leading childrens hospitals (e.g. Boston Children’s, Stanford, CHLA, Texas Childrens) voted GoCheck the #1 global pediatric health startup at SXSW 2018. Our Co-Founder and Chief Innovation Officer is David Huang, co-inventor of Optical Coherence Tomography, the most widely used diagnostic in ophthalmology. GoCheck is backed by Interwest Partners (90 IPOs) and Marc Benioff (Salesforce founder/CEO).

Founded in 2010, Doximity is the leading digital platform for medical professionals. The company’s network members include over 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and conduct virtual patient visits. Doximity’s mission is to help doctors be more productive so they can provide better healthcare for their patients. Learn more: https://linktr.ee/doximity

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.

At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.

At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.

Medical software providing diagnostic and surgical guidance for patient-specific spinal cord stimulation therapies.

Medical software providing diagnostic and surgical guidance for patient-specific spinal cord stimulation therapies.

STAAR, which has been dedicated solely to ophthalmic surgery for over 40 years, designs, develops, manufactures and markets implantable lenses for the eye. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery is called an Implantable Collamer® Lens or “ICL,” which includes the EVO ICL™ product line. More than 3,000,000 ICLs have been sold to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: EVOICL.com. Headquartered in Lake Forest, CA, the company operates manufacturing and packaging facilities in Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland. For more information, please visit the Company’s website at www.staar.com.

Centricity Vision has developed a medical device, ZEPTO® , that is a disposable capsulotomy device. Precise, strong, centered capsulotomies with 360° IOL overlap in the blink of an eye. Welcome to the Next Generation of ZEPTO® #zeptozone We are committed to providing high quality, automated capsulotomy devices that will become the standard of care for this procedure. We pursue innovation in all aspects of development and manufacturing to ensure we are providing the highest level of product quality, delivery and service.

We are an international non-profit that brings people together to fight avoidable blindness. With our network of partners we mentor, train and inspire local teams to fight blindness in their communities. We believe that no one should live a life of unnecessary blindness, simply because of where they were born.

Venus: A Global Leader In The Medical Aesthetics Industry We use cutting-edge technology to develop safe, non-invasive devices that address todays most in-demand aesthetic needs. As a leading medical aesthetic device company, we are currently present in over 60 countries and 29 direct markets with more than 10 million Venus treatments performed worldwide annually. Staying connected to our customers enables us to be focused on their needs and expectations and always provide them with the highest level of care – this is the essence of Aesthetic intelligence. Our latest innovations like Venus Bliss MAX™ the 3-in1-body shaping solution, ARTAS iXi® the A.I. hair restoration robot, NeoGraft®, Venus Legacy,™ Venus Velocity,™ Venus Viva™ MD—are setting higher industry standards and improving the quality of life for hundreds of thousands of patients worldwide. Looking to try a treatment? Find a certified provider near you: ‪http://www.venustreatments.com Are you a physician? Find out more: www.venus.ai